Dr. Madhu Gargesha of BioInVision presented a paper titled “MSC pre-treatments lead to better cell survival in mouse models of liver disease: A CryoViz Study” at the American Association of Immunologists (AAI) 2016 Conference in Seattle, Washington, USA, May 13-16 2016. The presentation was very well received and generated a lot of interest in the MERLIN project. You can find more details about the Conference here.
- Interesting read: Development, functional characterization, validation of phagocytic macrophages for liver cirrhosis t.co/5C5pQwXQns Time ago 2 Days via Hootsuite
- RT @EUSciComm: The EU Guide to Science Communication: Communicating Science — things to remember t.co/DEE2d878SZ … #SciCo… https:/… Time ago 2 Days via Hootsuite
- RT @EU_Health: #PublicConsultation Evaluation of the EU #blood and #tissues and #cells legislation. Deadline: 31.08.2017 t.co/wft9J… Time ago 2 Days via Hootsuite
Follow @fp7merlin on twitter.
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602363. The material presented and views expressed here are the responsibility of the author(s) only. The EU Commission takes no responsibility for any use made of the information set out.